Literature DB >> 15917567

In vitro activities of amphotericin B and voriconazole against aleurioconidia from Aspergillus terreus.

Cornelia Lass-Flörl1, Alexandra Rief, Sandra Leitner, Cornelia Speth, Reinhard Würzner, Manfred P Dierich.   

Abstract

This study used aleurioconidia as inoculum and compared the MICs of amphotericin B and voriconazole to those obtained for conidia of 31 Aspergillus terreus strains. For conidia and aleurioconidia, the MIC at which 90% of strains were inhibited was 2.5 microg/ml and 5 microg/ml with amphotericin B and 1 microg/ml and 2 microg/ml with voriconazole.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15917567      PMCID： PMC1140531          DOI： 10.1128/AAC.49.6.2539-2540.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  18 in total

1.  Aspergillus terreus infections in haematological malignancies: molecular epidemiology suggests association with in-hospital plants.

Authors:  C Lass-Flörl; P Rath; D Niederwieser; G Kofler; R Würzner; A Krezy; M P Dierich
Journal:  J Hosp Infect       Date:  2000-09       Impact factor: 3.926

Review 2.  Invasive aspergillosis.

Authors:  D W Denning
Journal:  Clin Infect Dis       Date:  1998-04       Impact factor: 9.079

3.  Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi.

Authors:  A Espinel-Ingroff; M Bartlett; R Bowden; N X Chin; C Cooper; A Fothergill; M R McGinnis; P Menezes; S A Messer; P W Nelson; F C Odds; L Pasarell; J Peter; M A Pfaller; J H Rex; M G Rinaldi; G S Shankland; T J Walsh; I Weitzman
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

4.  Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America.

Authors:  D A Stevens; V L Kan; M A Judson; V A Morrison; S Dummer; D W Denning; J E Bennett; T J Walsh; T F Patterson; G A Pankey
Journal:  Clin Infect Dis       Date:  2000-04-20       Impact factor: 9.079

Review 5.  Invasive pulmonary aspergillosis due to Aspergillus terreus: 12-year experience and review of the literature.

Authors:  P C Iwen; M E Rupp; A N Langnas; E C Reed; S H Hinrichs
Journal:  Clin Infect Dis       Date:  1998-05       Impact factor: 9.079

6.  In vitro amphotericin B resistance in clinical isolates of Aspergillus terreus, with a head-to-head comparison to voriconazole.

Authors:  D A Sutton; S E Sanche; S G Revankar; A W Fothergill; M G Rinaldi
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

7.  Activity of voriconazole (UK-109,496) against clinical isolates of Aspergillus species and its effectiveness in an experimental model of invasive pulmonary aspergillosis.

Authors:  M Murphy; E M Bernard; T Ishimaru; D Armstrong
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

Review 8.  Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review.

Authors:  E Anaissie
Journal:  Clin Infect Dis       Date:  1992-03       Impact factor: 9.079

9.  Studies of in vitro activities of voriconazole and itraconazole against Aspergillus hyphae using viability staining.

Authors:  C Lass-Flörl; M Nagl; C Speth; H Ulmer; M P Dierich; R Würzner
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

10.  Nosocomial pneumonia in patients having bone marrow transplant. Attributable mortality and risk factors.

Authors:  C Pannuti; R Gingrich; M A Pfaller; C Kao; R P Wenzel
Journal:  Cancer       Date:  1992-06-01       Impact factor: 6.860
View more
  8 in total

1.  Oxidative Stress Response Tips the Balance in Aspergillus terreus Amphotericin B Resistance.

Authors:  Emina Jukic; Michael Blatzer; Wilfried Posch; Marion Steger; Ulrike Binder; Cornelia Lass-Flörl; Doris Wilflingseder
Journal:  Antimicrob Agents Chemother       Date:  2017-09-22       Impact factor: 5.191

2.  Aspergillus terreus accessory conidia are multinucleated, hyperpolarizing structures that display differential dectin staining and can induce heightened inflammatory responses in a pulmonary model of aspergillosis.

Authors:  Eszter Deak; Michael Nelson; Yainitza Hernández-Rodríguez; Lalitha Gade; John Baddley; Michelle Momany; Chad Steele; S Arunmozhi Balajee
Journal:  Virulence       Date:  2011-05-01       Impact factor: 5.882

3.  Activities of antifungal agents against yeasts and filamentous fungi: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing.

Authors:  Cornelia Lass-Flörl; Astrid Mayr; Susanne Perkhofer; Guido Hinterberger; Johann Hausdorfer; Cornelia Speth; Manfred Fille
Journal:  Antimicrob Agents Chemother       Date:  2008-08-11       Impact factor: 5.191

4.  Virulence and thrombocyte affectation of two Aspergillus terreus isolates differing in amphotericin B susceptibility.

Authors:  Cornelia Speth; Gerhard Blum; Magdalena Hagleitner; Caroline Hörtnagl; Kristian Pfaller; Beate Posch; Helmut Werner Ott; Reinhard Würzner; Cornelia Lass-Flörl; Günter Rambach
Journal:  Med Microbiol Immunol       Date:  2013-05-31       Impact factor: 3.402

5.  Development and validation of a microsphere-based Luminex assay for rapid identification of clinically relevant aspergilli.

Authors:  Kizee A Etienne; Rui Kano; S Arunmozhi Balajee
Journal:  J Clin Microbiol       Date:  2009-02-25       Impact factor: 5.948

6.  Characterization of Aspergillus terreus Accessory Conidia and Their Interactions With Murine Macrophages.

Authors:  Isabell Henß; Christoph Kleinemeier; Lea Strobel; Matthias Brock; Jürgen Löffler; Frank Ebel
Journal:  Front Microbiol       Date:  2022-06-16       Impact factor: 6.064

7.  Aspergillus terreus accessory conidia are unique in surface architecture, cell wall composition and germination kinetics.

Authors:  Eszter Deak; Selwyn D Wilson; Elizabeth White; Janice H Carr; S Arunmozhi Balajee
Journal:  PLoS One       Date:  2009-10-30       Impact factor: 3.240

8.  Invasive Aspergillus terreus morphological transitions and immunoadaptations mediating antifungal resistance.

Authors:  Louis Bengyella; Elsie Laban Yekwa; Muhammad Nasir Subhani; Ernest Tambo; Kiran Nawaz; Bakoena Ashton Hetsa; Sehrish Iftikhar; Sayanika Devi Waikhom; Pranab Roy
Journal:  Infect Drug Resist       Date:  2017-11-07       Impact factor: 4.003
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.